輸入代號或公司名稱後按 Enter
4102

永日

+0.15 (+0.80%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
18.9523成交張數本益比1.33股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025474年增 -18.8%
毛利率202519.9%最新一期
營業利益率2025-4.2%最新一期
每股盈餘2025-0.34年增 -122.4%
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計99.2%80.3%82.9%72.0%70.9%78.1%70.9%68.9%69.4%80.1%
營業毛利(毛損)0.8%19.7%17.1%28.0%29.1%21.9%29.1%31.1%30.6%19.9%
營業毛利(毛損)淨額0.8%19.7%17.1%28.0%29.1%21.9%29.1%31.1%30.6%19.9%
推銷費用5.6%6.2%4.5%4.6%4.2%4.2%5.0%4.8%4.2%5.4%
管理費用13.1%12.5%11.2%10.7%11.5%9.7%9.3%10.2%10.3%11.9%
研究發展費用8.3%7.5%7.4%7.5%7.1%6.5%6.2%6.1%5.6%6.8%
營業費用合計27.0%26.3%23.2%22.7%22.8%20.4%20.5%21.1%20.1%24.1%
營業利益(損失)-26.2%-6.6%-6.1%5.3%6.3%1.5%8.6%10.0%10.5%-4.2%
利息收入0.0%0.0%0.1%0.4%0.2%0.1%
其他收入2.1%0.2%1.2%2.9%1.4%1.0%2.6%2.6%1.7%3.0%
其他利益及損失淨額-1.2%-1.4%0.4%-0.4%-1.2%-0.6%2.6%-0.3%1.5%-0.8%
財務成本淨額0.2%0.2%0.2%0.2%0.4%0.6%0.6%0.6%0.4%0.4%
營業外收入及支出合計0.7%-1.4%1.4%2.3%-0.2%-0.1%4.7%2.1%3.0%2.0%
稅前淨利(淨損)-25.5%-8.0%-4.7%7.5%6.1%1.4%13.3%12.1%13.5%-2.2%
所得稅費用(利益)合計-0.0%-0.0%-0.5%0.0%-0.3%-0.3%-0.1%0.2%1.5%-0.1%
繼續營業單位本期淨利(淨損)-25.5%-7.9%-4.2%7.5%6.5%1.7%13.4%11.9%12.0%-2.1%
本期淨利(淨損)-25.5%-7.9%-4.2%7.5%6.5%1.7%13.4%11.9%12.0%-2.1%
確定福利計畫之再衡量數0.7%0.2%-0.3%-0.7%-1.1%0.3%0.6%-0.1%0.2%1.1%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-4.3%7.1%-3.7%0.1%6.8%-1.6%-0.5%-4.2%
與不重分類之項目相關之所得稅0.1%0.0%-0.9%0.9%-0.7%0.3%1.5%-0.5%-0.0%-0.3%
不重分類至損益之項目:5.5%-4.1%0.1%5.9%-1.2%-0.3%-2.7%
其他綜合損益(淨額)0.6%0.2%-3.7%5.5%-4.1%0.1%5.9%-1.2%-0.3%-2.7%
本期綜合損益總額-24.9%-7.8%-7.9%13.0%2.3%1.8%19.3%10.7%11.7%-4.9%
母公司業主(淨利∕損)-4.2%7.5%6.6%1.3%12.3%11.2%11.1%-3.0%
非控制權益(淨利∕損)0.0%0.0%-0.2%0.4%1.0%0.7%0.9%0.9%
母公司業主(綜合損益)-7.9%13.0%2.5%1.3%18.3%10.0%10.7%-5.8%
非控制權益(綜合損益)0.0%-0.2%0.4%1.0%0.7%0.9%0.9%
基本每股盈餘-0.6%-0.2%-0.1%0.2%0.2%0.0%0.3%0.3%0.3%-0.1%
繼續營業單位淨利(淨損)-0.0%-0.0%-0.0%0.0%0.0%0.0%0.0%0.0%0.0%-0.0%
稀釋每股盈餘0.2%0.0%0.3%0.3%0.3%-0.1%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。